26 4月 2024 by admin in UncategorizedComments Crescendo Biologics announces that Zai Lab has initiated a global Phase 2 clinical trial evaluating ZL-1102 (Humabody®, CB001) as a topical treatment for psoriasis
08 4月 2024 by admin in UncategorizedComments Adcentrx Therapeutics Appoints Meng Jiang as Chief Financial Officer
29 3月 2024 by admin in UncategorizedComments 礼邦医药在研创新药物 AP303 获得美国食品药品监督管理局(FDA)孤儿药 资格认定, 用于治疗常染色体显性多囊肾病(ADPKD)
26 3月 2024 by admin in UncategorizedComments Avenzo Therapeutics Announces $150 Million Oversubscribed Financing To Advance Emerging Oncology Pipeline
06 3月 2024 by admin in UncategorizedComments Zenas BioPharma Appoints Patricia Allen to its Board of Directors
07 2月 2024 by admin in UncategorizedComments Sail Biomedicines Appoints Kerry Benenato, Ph.D., as Chief Platform Officer
29 1月 2024 by admin in UncategorizedComments 原启生物宣布 FDA 批准其靶向 GPRC5D CAR-T 产品 OriCAR-017 的 IND 申请，该产品用于治疗复发/难治性 多发性骨髓瘤
25 1月 2024 by admin in UncategorizedComments Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
18 1月 2024 by admin in UncategorizedComments NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
15 1月 2024 by admin in UncategorizedComments Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
